Dichloromethane → 4-[5-(2-Amino-ethyl)-2-methyl-imidazol-1-ylmethyl]-2-[3-(3-ethyl-1-methyl-2-oxo-azepan-3-yl)-phenoxy]-benzonitrile dihydrochloride

HRID 1594862ノート

反応式

HRID 1594862 の反応式
C(OC(=O)[NH:7][CH2:8][CH2:9][C:10]1[N:11]([CH2:16][C:17]2[CH:22]=[CH:21][C:20]([C:23]#[N:24])=[C:19]([O:25][C:26]3[CH:31]=[CH:30][CH:29]=[C:28]([C:32]4([CH2:41][CH3:42])[CH2:38][CH2:37][CH2:36][CH2:35][N:34]([CH3:39])[C:33]4=[O:40])[CH:27]=3)[CH:18]=2)[C:12]([CH3:15])=[N:13][CH:14]=1)(C)(C)C.C(O)(C(F)(F)F)=O.C(Cl)[Cl:52]>>[ClH:52].[ClH:52].[NH2:7][CH2:8][CH2:9][C:10]1[N:11]([CH2:16][C:17]2[CH:22]=[CH:21][C:20]([C:23]#[N:24])=[C:19]([O:25][C:26]3[CH:31]=[CH:30][CH:29]=[C:28]([C:32]4([CH2:41][CH3:42])[CH2:38][CH2:37][CH2:36][CH2:35][N:34]([CH3:39])[C:33]4=[O:40])[CH:27]=3)[CH:18]=2)[C:12]([CH3:15])=[N:13][CH:14]=1

参加物

4

実験手順

To a solution of [2-(3-{4-cyano-3-[3-(3-ethyl-1-methyl-2-oxo-azepan-3-yl)-phenoxy]-benzyl}-2-methyl-3H-imidazol-4-yl)-ethyl]-carbamic acid tert-butyl ester (as described in Step B above) (0.2 g, 0.41 mmol) in CH2Cl2 (6.0 mL) was added TFA (3.0 mL) and the solution was stirred for 0.5 hr. The solvents were removed in vacuo and the crude product was purified by preparative HPLC. Conversion to the HCl salt yielded the title compound.

後処理

  1. customThe solvents were removed in vacuo
  2. customthe crude product was purified by preparative HPLC

出典と根拠

ORDレコード
ord-c747706e699b4895b0ac98161f3d528b
出典データセット
uspto-grants-2001_09
特許番号
US06284755B1

反応ノート

読み込み中…